- Home
- NRC vs ETON Comparison
NRC vs ETON Comparison
Compare NRC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRC | ETON |
|---|---|---|
| Founded | 1981 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.2M | 411.9M |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NRC | ETON |
|---|---|---|
| Price | $16.52 | $18.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $31.00 |
| AVG Volume (30 Days) | 100.9K | ★ 291.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.88% | N/A |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 50.00 | N/A |
| Revenue | ★ $119,686,000.00 | $39,011,000.00 |
| Revenue This Year | N/A | $107.23 |
| Revenue Next Year | N/A | $29.72 |
| P/E Ratio | $0.33 | ★ N/A |
| Revenue Growth | 1.81 | ★ 23.29 |
| 52 Week Low | $9.76 | $11.09 |
| 52 Week High | $22.79 | $23.00 |
Technical Indicators
Market Signals| Indicator | NRC | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 58.97 | 64.96 |
| Support Level | $14.78 | $16.04 |
| Resistance Level | $16.63 | $20.01 |
| Average True Range (ATR) | 0.89 | 1.08 |
| MACD | 0.60 | 0.10 |
| Stochastic Oscillator | 89.28 | 70.56 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.